Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor

Phelan–McDermid syndrome (PMS), caused by pathogenic variants in the <i>SHANK3</i> gene or 22q13 deletions, is characterized by intellectual disability, autistic features, developmental delays, and neonatal hypotonia. Insulin-like growth factor 1 (IGF-1) and human growth hormone (hGH) ha...

Full description

Bibliographic Details
Main Authors: Bridgette A. Moffitt, Sara M. Sarasua, Diana Ivankovic, Linda D. Ward, Kathleen Valentine, William E. Bennett, Curtis Rogers, Katy Phelan, Luigi Boccuto
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/14/2/490
_version_ 1797620790218194944
author Bridgette A. Moffitt
Sara M. Sarasua
Diana Ivankovic
Linda D. Ward
Kathleen Valentine
William E. Bennett
Curtis Rogers
Katy Phelan
Luigi Boccuto
author_facet Bridgette A. Moffitt
Sara M. Sarasua
Diana Ivankovic
Linda D. Ward
Kathleen Valentine
William E. Bennett
Curtis Rogers
Katy Phelan
Luigi Boccuto
author_sort Bridgette A. Moffitt
collection DOAJ
description Phelan–McDermid syndrome (PMS), caused by pathogenic variants in the <i>SHANK3</i> gene or 22q13 deletions, is characterized by intellectual disability, autistic features, developmental delays, and neonatal hypotonia. Insulin-like growth factor 1 (IGF-1) and human growth hormone (hGH) have been shown to reverse neurobehavioral deficits in PMS. We assessed the metabolic profiling of 48 individuals with PMS and 50 controls and determined subpopulations by taking the top and bottom 25% of responders to hGH and IGF-1. A distinct metabolic profile for individuals with PMS showed a reduced ability to metabolize major energy sources and a higher metabolism of alternative energy sources. The analysis of the metabolic response to hGH or IGF-1 highlighted a major overlap between both high and low responders, validating the model and suggesting that the two growth factors share many target pathways. When we investigated the effect of hGH and IGF-1 on the metabolism of glucose, the correlation between the high-responder subgroups showed less similarity, whereas the low-responders were still relatively similar. Classification of individuals with PMS into subgroups based on responses to a compound can allow an investigation into pathogenic mechanisms, the identification of molecular biomarkers, an exploration of in vitro responses to candidate drugs, and eventually the selection of better candidates for clinical trials.
first_indexed 2024-03-11T08:46:37Z
format Article
id doaj.art-21baf555c4e947fa942fbdef0fffc489
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-11T08:46:37Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-21baf555c4e947fa942fbdef0fffc4892023-11-16T20:43:42ZengMDPI AGGenes2073-44252023-02-0114249010.3390/genes14020490Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth FactorBridgette A. Moffitt0Sara M. Sarasua1Diana Ivankovic2Linda D. Ward3Kathleen Valentine4William E. Bennett5Curtis Rogers6Katy Phelan7Luigi Boccuto8School of Nursing, Healthcare Genetics Program, Clemson University, Clemson, SC 29634, USASchool of Nursing, Healthcare Genetics Program, Clemson University, Clemson, SC 29634, USASchool of Nursing, Healthcare Genetics Program, Clemson University, Clemson, SC 29634, USASchool of Nursing, Healthcare Genetics Program, Clemson University, Clemson, SC 29634, USASchool of Nursing, Healthcare Genetics Program, Clemson University, Clemson, SC 29634, USADivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Indiana University, Riley Hospital for Children, Indianapolis, IN 46202, USAGreenwood Genetic Center, Greenwood, SC 29646, USAGenetics Laboratory, Florida Cancer Specialists & Research Institute, Fort Myers, FL 33916, USASchool of Nursing, Healthcare Genetics Program, Clemson University, Clemson, SC 29634, USAPhelan–McDermid syndrome (PMS), caused by pathogenic variants in the <i>SHANK3</i> gene or 22q13 deletions, is characterized by intellectual disability, autistic features, developmental delays, and neonatal hypotonia. Insulin-like growth factor 1 (IGF-1) and human growth hormone (hGH) have been shown to reverse neurobehavioral deficits in PMS. We assessed the metabolic profiling of 48 individuals with PMS and 50 controls and determined subpopulations by taking the top and bottom 25% of responders to hGH and IGF-1. A distinct metabolic profile for individuals with PMS showed a reduced ability to metabolize major energy sources and a higher metabolism of alternative energy sources. The analysis of the metabolic response to hGH or IGF-1 highlighted a major overlap between both high and low responders, validating the model and suggesting that the two growth factors share many target pathways. When we investigated the effect of hGH and IGF-1 on the metabolism of glucose, the correlation between the high-responder subgroups showed less similarity, whereas the low-responders were still relatively similar. Classification of individuals with PMS into subgroups based on responses to a compound can allow an investigation into pathogenic mechanisms, the identification of molecular biomarkers, an exploration of in vitro responses to candidate drugs, and eventually the selection of better candidates for clinical trials.https://www.mdpi.com/2073-4425/14/2/490Phelan–McDermid syndromePMS22q13.3 deletion syndrome<i>SHANK3</i>growth hormonehGH
spellingShingle Bridgette A. Moffitt
Sara M. Sarasua
Diana Ivankovic
Linda D. Ward
Kathleen Valentine
William E. Bennett
Curtis Rogers
Katy Phelan
Luigi Boccuto
Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor
Genes
Phelan–McDermid syndrome
PMS
22q13.3 deletion syndrome
<i>SHANK3</i>
growth hormone
hGH
title Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor
title_full Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor
title_fullStr Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor
title_full_unstemmed Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor
title_short Stratification of a Phelan–McDermid Syndrome Population Based on Their Response to Human Growth Hormone and Insulin-like Growth Factor
title_sort stratification of a phelan mcdermid syndrome population based on their response to human growth hormone and insulin like growth factor
topic Phelan–McDermid syndrome
PMS
22q13.3 deletion syndrome
<i>SHANK3</i>
growth hormone
hGH
url https://www.mdpi.com/2073-4425/14/2/490
work_keys_str_mv AT bridgetteamoffitt stratificationofaphelanmcdermidsyndromepopulationbasedontheirresponsetohumangrowthhormoneandinsulinlikegrowthfactor
AT saramsarasua stratificationofaphelanmcdermidsyndromepopulationbasedontheirresponsetohumangrowthhormoneandinsulinlikegrowthfactor
AT dianaivankovic stratificationofaphelanmcdermidsyndromepopulationbasedontheirresponsetohumangrowthhormoneandinsulinlikegrowthfactor
AT lindadward stratificationofaphelanmcdermidsyndromepopulationbasedontheirresponsetohumangrowthhormoneandinsulinlikegrowthfactor
AT kathleenvalentine stratificationofaphelanmcdermidsyndromepopulationbasedontheirresponsetohumangrowthhormoneandinsulinlikegrowthfactor
AT williamebennett stratificationofaphelanmcdermidsyndromepopulationbasedontheirresponsetohumangrowthhormoneandinsulinlikegrowthfactor
AT curtisrogers stratificationofaphelanmcdermidsyndromepopulationbasedontheirresponsetohumangrowthhormoneandinsulinlikegrowthfactor
AT katyphelan stratificationofaphelanmcdermidsyndromepopulationbasedontheirresponsetohumangrowthhormoneandinsulinlikegrowthfactor
AT luigiboccuto stratificationofaphelanmcdermidsyndromepopulationbasedontheirresponsetohumangrowthhormoneandinsulinlikegrowthfactor